Immunotherapies catering to the unmet medical need of cold colorectal cancer
As a common malignant tumor of gastrointestinal tract, the incidence of colorectal cancer (CRC) has gradually increased in recent years. In western developed countries, it has even become the second largest malignant tumor next to lung cancer. Immunotherapy is a hot topic in the field of cancer ther...
Main Authors: | Jun Yuan, Jiarui Li, Ce Gao, Chun Jiang, Ze Xiang, Jian Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1022190/full |
Similar Items
-
The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer
by: Brigida Anna Maiorano, et al.
Published: (2022-10-01) -
Immunotherapy of hepatocellular carcinoma: recent progress and new strategy
by: Jiarui Li, et al.
Published: (2023-05-01) -
Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers
by: Lindsey Carlsen, et al.
Published: (2022-02-01) -
Immunotherapy regimens for metastatic colorectal carcinomas
by: Babar Bashir, et al.
Published: (2018-02-01) -
Colorectal Cancer Immunotherapy: State of the Art and Future Directions
by: Alyssa Mauri Cornista, et al.
Published: (2023-01-01)